Pfizer (PFE), Valneva (VALN) Lyme Vaccine Moves to EMA Review Despite Phase 3 Caveat

Stocks Yahoo Finance By Yahoo Finance 15 Sep 2026 16:21 1 min read
Pfizer (PFE), Valneva (VALN) Lyme Vaccine Moves to EMA Review Despite Phase 3 Caveat

Covered in this story

Dalsna Finance is currently tracking 49 stories mentioning Pfizer, the earliest published 22 Apr 2026.

Read the full story on Yahoo Finance → Opens the original article on finance.yahoo.com

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.